- Home
- TIL vs GF Comparison
TIL vs GF Comparison
Compare TIL & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- GF
- Stock Information
- Founded
- TIL 2018
- GF 1990
- Country
- TIL United States
- GF Germany
- Employees
- TIL N/A
- GF N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- GF Investment Managers
- Sector
- TIL Health Care
- GF Finance
- Exchange
- TIL Nasdaq
- GF Nasdaq
- Market Cap
- TIL 171.7M
- GF 155.4M
- IPO Year
- TIL 2021
- GF N/A
- Fundamental
- Price
- TIL $26.95
- GF $11.59
- Analyst Decision
- TIL Buy
- GF
- Analyst Count
- TIL 5
- GF 0
- Target Price
- TIL $119.00
- GF N/A
- AVG Volume (30 Days)
- TIL 316.4K
- GF 28.1K
- Earning Date
- TIL 05-13-2025
- GF 01-01-0001
- Dividend Yield
- TIL N/A
- GF 0.82%
- EPS Growth
- TIL N/A
- GF N/A
- EPS
- TIL N/A
- GF N/A
- Revenue
- TIL N/A
- GF N/A
- Revenue This Year
- TIL N/A
- GF N/A
- Revenue Next Year
- TIL N/A
- GF N/A
- P/E Ratio
- TIL N/A
- GF N/A
- Revenue Growth
- TIL N/A
- GF N/A
- 52 Week Low
- TIL $9.62
- GF $7.38
- 52 Week High
- TIL $92.00
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- TIL 65.08
- GF 75.39
- Support Level
- TIL $12.60
- GF $11.34
- Resistance Level
- TIL $35.28
- GF $11.72
- Average True Range (ATR)
- TIL 3.84
- GF 0.16
- MACD
- TIL 1.60
- GF 0.02
- Stochastic Oscillator
- TIL 63.27
- GF 85.56
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.